Chronic illnesses, and the rising costs of treating them, are a growing concern for benefits plan sponsors.
At the 2015 Calgary Drug Trends Summit, experts discussed topics ranging from new treatments—such as biologics and subsequent-entry biologics—to cardiovascular disease and obesity, to the physical and mental anguish endured by patients with chronic illnesses. Here are highlights from the sessions.
Psoriasis – A look below the surface
At the age of 35, Andrew Gosse was tired of living. A psoriasis patient for more than half his life, he told his wife, “This disease has ravaged me. I’ve tried everything. I’ve tried every medication the dermatologist could prescribe; I’ve tried all the cures on the Internet.”
Read more…
The advent of biosimilars in Canada: Balancing short-term opportunity and long-term sustainability
Biologics represent a substantive and growing portion of total drug spending in Canada.
Read more…
Managing cardiovascular disease – Impact on the workplace
Thanks to advances in medical treatments over the past four decades, a study from the Public Health Agency of Canada shows that fewer people are now dying of heart attacks.
Read more…
Obesity management at the workplace
Obesity is a chronic medical condition and a major public health problem affecting one in four Canadian adults, according to the Public Health Agency of Canada.
Read more…
What’s causing your insomnia? Drug trends that are keeping you up at night
Attention deficit hyperactivity disorder (ADHD) has huge organizational and individual costs.
Read more…